NCT00778778View on ClinicalTrials.gov

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2005

Conditions
Healthy
Interventions
DRUG

cefprozil 500mg tablets

Trial Locations (1)

H4R2N6

MDS Pharma Services, Saint-Laurent, Montreal

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778778 - Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions | Biotech Hunter | Biotech Hunter